Peptides have quickly become one of the top questions from my patients. Everyday someone asks, “Doc, which peptides actually work?” Peptide therapy can be both exciting and confusing. My goal here is to cut through marketing hype to highlight my actual clinical observations based on outcomes and real patient results. I will review six of the most-talked-about peptides (and one nonpeptide that deserves its place at the top). Each will be ranked based on evidence level, ranging from solid human trials to promising and then experimental options, so you can better understand where each option stands for your health and what impact they could have.
What Is Peptide Therapy, Really?
Peptides are short chains of amino acids, fragments of proteins that act as signaling molecules within your body. Each peptide consists of multiple amino acids linked together and forms an individual sequence which “speaks” with all your tissues and cells in specific ways.
Peptides target specific tissues to stimulate specific processes, much like hormones do. Therefore, one way of viewing peptide therapy is as targeted signalling. Peptides nudge your body towards better healing, metabolism or recovery.
These peptides differ significantly from over-the-counter collagen peptide supplements you might mix into your coffee, though both can provide benefits to skin, joints, and gut lining. While those may help, peptides are prescription-grade, highly specific, and more potent in terms of effects.
Low-Dose Naltrexone (LDN): The Gold Standard
LDN may not technically qualify as a peptide therapy, but I am going to mention it because of its strong human data and efficacy at lower doses than any peptide. When taken at doses between 1.5 mg and 4.5 mg, LDN acts quite differently from what we’d find at its FDA-approved levels.
LDN temporarily blocks certain opioid receptors in your body. As a result, more endorphins and enkephalins are produced internally, producing not just pain relief. The real benefit is the downstream anti-inflammatory and immune-modulating benefits.
Multiple Sclerosis, Crohn’s Disease, Fibromyalgia and Chronic Pain can benefit from LDN treatments; there have been real human clinical studies published, peer-reviewed studies which demonstrate this efficacy, not simply animal data or theories. I often witness patients with chronic inflammation finally losing weight once we add LDN into their protocol when already taking GLP-1 medications or diets with anti-inflammatories. We often observe improvements in gut health/gut/Sleep health/Sleep issues/Mood Stability, and pain levels.
LDN therapy may help ease symptoms in those suffering from chronic inflammatory conditions or conditions associated with postviral syndromes and PCOS by modulating rather than suppressing an overreacting immune system.
From my perspective, LDN is the gold standard in this space for treating any ongoing inflammation issues.
BPC‑157: The Tissue Healer
BPC-157 is one of the most frequently utilized peptides in functional and regenerative medicine. As it comes from gastric juice proteins, this fragment could potentially play a part in protecting and healing gut lining issues.
Though we lack completed human trials yet, BPC-157 remains one of the most commonly seen peptides producing real results in my practice.
BPC-157 can help to alleviate many intestinal disorders in oral form: IBS, leaky gut syndrome, chronic bloating and unexplained digestive problems, as well as inflammatory bowel conditions. Patients suffering for years often see substantial relief within weeks when combined with BPC-157 in an effective regimen designed for them.
BPC-157 injectable forms tend to perform best for treating soft tissue injuries like joint pain, tendonitis, ligament strains and soft tissue tears. Reported faster healing time and reduced pain relief for athletes when used as part of a recovery program, which includes proper rehabilitation, nutrition and load management strategies.
Experience has taught me that BPC-157 can serve as an excellent starting point in terms of peptide therapy for gut healing and musculoskeletal repair, particularly when other methods only provide partial relief.
KPV: The Inflammation Fighter
KPV may only contain three amino acids, but its impact on inflammation is tremendous. It is part of the alpha-MSH naturally within our bodies as an anti-inflammatory regulator.
No human trials yet, but we do possess strong cell culture and animal data on KPV for colitis and related inflammatory conditions. KPV helps dampen inflammation pathways at a cellular level.
Clinically, KPV works well when taken together with BPC-157 as part of a combined supplement capsule to address inflammation from different angles. I find it especially effective for treating autoimmune conditions, chronic skin issues like eczema and inflammation of the digestive tract-. Particularly beneficial when combined with diet or lifestyle interventions.
Peptides like KPV should not be seen as solutions in themselves. Rather, they help manage inflammation so your body can heal more efficiently during lifestyle changes.Peptides should be used as an effective management tool and catalyst of change. KPV deserves its place among my promising collection of peptide therapies.
TB‑500: Recovery and Performance
TB‑500, a fragment of thymosin beta‑4, is naturally associated with tissue repair responses. Most of the published data to date comes from animal models, including racehorses with tendon injuries. There are no robust human trials yet, but the mechanisms, enhanced cell migration, angiogenesis, and tissue remodeling.
In practice, I see TB‑500 used most frequently among serious athletes, but it’s not limited to them. When combined with injectable BPC‑157, the idea is that BPC‑157 drives deep tissue healing while TB‑500 enhances cell movement and vascular support to the injured area.
Patients who are training hard and not recovering well, or those with chronic injury patterns, often notice faster recovery times, less soreness, and better performance when TB‑500 is carefully integrated into a broader, monitored plan. For that reason, I place TB‑500 in the “promising for recovery” category within peptide therapy.
SLT‑332 (Sloop 332): The Fat-Mobilizing “Exercise in a Bottle”
Sloop 332 (sometimes written as SLT‑332) is one of the more experimental yet intriguing peptides I work with. Its proposed mechanism is mitochondrial uncoupling, essentially making your cells burn more calories as heat and mobilize fat more effectively.
There is very limited published human data at this point. However, some patients report meaningful benefits: cleaner fat loss, better energy, and improved recovery when Sloop 332 is layered onto an already strong protocol that includes fasting, dietary change, and inflammation control.
Where I see this peptide shine is in complex metabolic cases from menopause, PCOS, severe metabolic damage, and stubborn weight-loss resistance, even after GLP‑1 medications and other tools have been optimized. When patients fast, cortisol naturally rises. For some metabolically fragile individuals, that extra stress pushes them over the edge. Adding Sloop 332 during fasting windows seems, in some cases, to help their bodies actually access and burn stored fat instead of simply triggering more stress.
This is not a first‑line tool. It’s experimental and best reserved for early adopters who understand the uncertainties, have already tried more proven strategies, and are working closely with a clinician who can monitor labs and symptoms.
5‑Amino‑1MQ: For True Early Adopters
5‑Amino‑1MQ is one of the newest and most experimental options in peptide therapy. It works by inhibiting the NNMT enzyme, which is involved in slowing metabolism as we age. Mouse studies show increased metabolic rate and reduced fat mass, but translating that into safe and consistent human outcomes is still a work in progress.
In the limited cases I’ve seen, 5‑Amino‑1MQ can help certain patients break through stubborn plateaus when everything else has been optimized. That said, I consider it a step beyond Sloop 332 in terms of experimental status. If a patient is interested in this peptide, I make sure they fully understand they’re participating in the early stages of discovery.
Because it is oral and relatively convenient, it’s tempting for people to jump straight to it. I do not recommend that. It belongs in the hands of very informed, very motivated patients under close medical supervision.
How I Choose the Right Peptide Therapy for a Patient
When I think about peptide therapy, I visualize a pyramid. At the top is proven, human clinical trial data; right now, that’s where LDN sits. Below that is the promising layer: BPC‑157, KPV, and TB‑500 supported by strong mechanisms, animal data, and significant clinical experience. At the base is the emerging experimental tier, where SLT‑332 and 5‑Amino‑1MQ currently lives.
As we move down the pyramid, the strength of the evidence decreases, but the potential for innovation increases. Some patients need rock‑solid options and are not comfortable with uncertainty. Others have exhausted conventional methods and are ready to explore therapies with appropriate oversight.
Whether we’re focusing on inflammation, gut health, recovery, or metabolic repair, peptide therapy is never a standalone magic fix. It’s a powerful tool that must be combined with nutrition, lifestyle, and work to create meaningful, sustainable change.
If you are considering peptide therapy, do it safely. Work with a qualified provider who uses pharmaceutical‑grade peptides from licensed compounding pharmacies, tracks your blood work and symptoms. That is the kind of evidence‑based, patient‑centered approach I bring to my practice, and it’s how I believe peptide therapy can transform health without sacrificing safety or integrity.
DISCLAIMER
The content provided on this website is for informational purposes only. It is not a substitute for professional diagnosis, treatment or medical advice. There is no assurance or warranty regarding the accuracy and applicability of the content. Never ignore professional medical advice in seeking treatment because of something you have read on the website.
